The drug development process is long and expensive with more failures than successes.

At Certara, we support confident decision-making throughout the entire drug development process with our gold-standard software and technology-enabled services, helping our partners to reduce cycle times, lower costs, and improve outcomes for patients. In fact, eleven regulatory agencies worldwide have adopted our Phoenix™ PK/PD and/or Simcyp™ PBPK Simulator software platforms, including the US FDA and EMA.

Our results speak for themselves. 90% of new drug approvals by the FDA have been supported by our software or services since 2014.